Afro-Egyptian Journal of Infectious and Endemic Diseases · Sep 12, 2026
Hypertension among South African Adults Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy: A Scoping Review
By Lewis MSP, Pillay S
Background and study aim: Dolutegravir (DTG)-based antiretroviral therapy (ART) has transformed HIV outcomes in South Africa, but ageing and weight gain have raised concern regarding hypertension (HPT) among people living with HIV (PLHIV). This scoping review mapped HPT burden, control, metabolic factors and care models among South African adults receiving DTG-based ART or studied during DTG rollout.Methods: The review was conducted and reported in accordance with PRISMA-ScR. PubMed, Scopus and Web of Science were searched for studies published from 2016 to 2025. Eligible studies reported HPT outcomes in South African adult PLHIV with documented DTG exposure or during rollout. Outcomes were classified as prevalence or proportion, cumulative risk or treatment-emergent HPT over a stated follow-up period at stated follow-up, and blood pressure control. Study duration, ART/DTG exposure and metabolic factors were charted.Results: Ten studies were included. Cross-sectional HPT estimates ranged from approximately 15% in younger cohorts to over 30% among older adults, although definitions and denominators varied. Longitudinal follow-up ranged from 6 months to 96 weeks, but new-onset or treatment-emergent HPT was infrequently reported. Increased HPT risk after switching to DTG and rising blood pressure after ART initiation were associated with weight gain and older age. Fewer than 40% of treated individuals achieved blood pressure control in the study that explicitly defined control; uncontrolled HPT was associated with increased all-cause mortality. Other reported metabolic factors included overweight or obesity, dyslipidaemia, diabetes or glycaemic measures, and kidney function, but were inconsistently assessed. Integrated HIV-HPT care was feasible, whereas differentiated ART models rarely included cardiometabolic surveillance.Conclusion: Hypertension is common and often poorly controlled among South African adults living with HIV in the DTG era. Evidence is limited by inconsistent outcome definitions, incomplete confirmation of DTG exposure and short follow-up. Routine blood pressure screening and integrated cardiometabolic assessment should be embedded within HIV care; longer-term DTG-specific studies are needed.
doi.org/10.21608/aeji.2026.509876.1571Open accessInterventions